431 related articles for article (PubMed ID: 28252822)
1. Diagnostic performance between contrast enhancement, proton MR spectroscopy, and amide proton transfer imaging in patients with brain tumors.
Sakata A; Fushimi Y; Okada T; Arakawa Y; Kunieda T; Minamiguchi S; Kido A; Sakashita N; Miyamoto S; Togashi K
J Magn Reson Imaging; 2017 Sep; 46(3):732-739. PubMed ID: 28252822
[TBL] [Abstract][Full Text] [Related]
2. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
[TBL] [Abstract][Full Text] [Related]
3. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
5. Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI).
Su C; Zhao L; Li S; Jiang J; Cai K; Shi J; Yao Y; Ao Q; Zhang G; Shen N; Hu S; Zhang J; Qin Y; Zhu W
Eur Radiol; 2019 Mar; 29(3):1203-1210. PubMed ID: 30105412
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
[TBL] [Abstract][Full Text] [Related]
7. Pre- and Posttreatment Glioma: Comparison of Amide Proton Transfer Imaging with MR Spectroscopy for Biomarkers of Tumor Proliferation.
Park JE; Kim HS; Park KJ; Kim SJ; Kim JH; Smith SA
Radiology; 2016 Feb; 278(2):514-23. PubMed ID: 26491847
[TBL] [Abstract][Full Text] [Related]
8. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
9. Grading glial tumors with amide proton transfer MR imaging: different analytical approaches.
Sakata A; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Dodo T; Arakawa Y; Schmitt B; Miyamoto S; Togashi K
J Neurooncol; 2015 Apr; 122(2):339-48. PubMed ID: 25559689
[TBL] [Abstract][Full Text] [Related]
10. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
[TBL] [Abstract][Full Text] [Related]
11. Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma.
Park KJ; Kim HS; Park JE; Shim WH; Kim SJ; Smith SA
Eur Radiol; 2016 Dec; 26(12):4390-4403. PubMed ID: 26883333
[TBL] [Abstract][Full Text] [Related]
12. Histogram Analysis of Amide Proton Transfer Imaging to Identify Contrast-enhancing Low-Grade Brain Tumor That Mimics High-Grade Tumor: Increased Accuracy of MR Perfusion.
Park JE; Kim HS; Park KJ; Choi CG; Kim SJ
Radiology; 2015 Oct; 277(1):151-61. PubMed ID: 25910226
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of Meningiomas and Gliomas by Amide Proton Transfer Imaging: A Preliminary Study of Brain Tumour Infiltration.
Zhang HW; Liu XL; Zhang HB; Li YQ; Wang YL; Feng YN; Deng K; Lei Y; Huang B; Lin F
Front Oncol; 2022; 12():886968. PubMed ID: 35646626
[TBL] [Abstract][Full Text] [Related]
14. Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T.
Meissner JE; Korzowski A; Regnery S; Goerke S; Breitling J; Floca RO; Debus J; Schlemmer HP; Ladd ME; Bachert P; Adeberg S; Paech D
J Magn Reson Imaging; 2019 Oct; 50(4):1268-1277. PubMed ID: 30864193
[TBL] [Abstract][Full Text] [Related]
15. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
16. Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location.
Dreher C; Oberhollenzer J; Meissner JE; Windschuh J; Schuenke P; Regnery S; Sahm F; Bickelhaupt S; Bendszus M; Wick W; Unterberg A; Zaiss M; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Paech D
J Magn Reson Imaging; 2019 Mar; 49(3):777-785. PubMed ID: 30133046
[TBL] [Abstract][Full Text] [Related]
17. Amide proton transfer imaging of brain tumors using a self-corrected 3D fast spin-echo dixon method: Comparison With separate B
Togao O; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Yoneyama M; Honda H
Magn Reson Med; 2017 Jun; 77(6):2272-2279. PubMed ID: 27385636
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas.
Ikeguchi R; Shimizu Y; Abe K; Shimizu S; Maruyama T; Nitta M; Abe K; Kawamata T; Kitagawa K
Mult Scler Relat Disord; 2018 Nov; 26():77-84. PubMed ID: 30237108
[TBL] [Abstract][Full Text] [Related]
19. Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.
Park JE; Lee JY; Kim HS; Oh JY; Jung SC; Kim SJ; Keupp J; Oh M; Kim JS
Eur Radiol; 2018 Aug; 28(8):3285-3295. PubMed ID: 29488086
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
Debnath A; Gupta RK; Singh A
Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
